Details
Stereochemistry | ACHIRAL |
Molecular Formula | Cl.K |
Molecular Weight | 74.551 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].[K+]
InChI
InChIKey=WCUXLLCKKVVCTQ-UHFFFAOYSA-M
InChI=1S/ClH.K/h1H;/q;+1/p-1
Molecular Formula | K |
Molecular Weight | 39.0983 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Potassium is needed to maintain good health. When potassium level falls below 3.5 mmol/L, Hypokalemia is diagnosed. In case of extremely low level of potassium (lower than 2.5 mmol/L) the following symptoms are appeared: malaise and fatigue. This low level of potassium can lead to severe muscle weakness and paralysis; respiratory failure; intermittent muscle spasms. It is known, foods that are good sources of potassium and low in sodium may reduce the risk of high blood pressure and stroke. Potassium supplementation is also recommended as an adjuvant antihypertensive agent for patients with essential hypertension.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 04:51:26 GMT 2023
by
admin
on
Sat Dec 16 04:51:26 GMT 2023
|
Record UNII |
660YQ98I10
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 184.1622
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
26.1
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
||
|
WHO-ATC |
B05XA01
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
||
|
WHO-VATC |
QA12BA01
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
||
|
JECFA EVALUATION |
INS-508
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
||
|
NCI_THESAURUS |
C29730
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
||
|
WHO-VATC |
QB05XA01
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
||
|
DSLD |
2903 (Number of products:117)
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
||
|
WHO-ATC |
A12BA01
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
||
|
EPA PESTICIDE CODE |
13904
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
||
|
FDA ORPHAN DRUG |
403513
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
26.2
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
||
|
FDA ORPHAN DRUG |
616817
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
||
|
WHO-VATC |
QA12BA51
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
||
|
WHO-ATC |
A12BA51
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
||
|
CODEX ALIMENTARIUS (GSFA) |
INS-508
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
7447-40-7
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | |||
|
660YQ98I10
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | |||
|
32588
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | |||
|
77368
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | |||
|
231-211-8
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | |||
|
8591
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | RxNorm | ||
|
C47679
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | |||
|
CHEMBL1200731
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | |||
|
1548190
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | |||
|
POTASSIUM CHLORIDE
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | |||
|
660YQ98I10
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | |||
|
4873
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | |||
|
POTASSIUM CHLORIDE
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | Description: Colourless crystals or a white, crystalline powder; odourless. Solubility: Soluble in 3 parts of water; practically insoluble in ethanol (~750 g/l) TS. Category: Ionic equilibration agent. Storage: Potassium chloride should be kept in a well-closed container.Labelling. The designation Potassium chloride for parenteral use indicates that the substance complies with the additionalrequirement given at the end of this monograph and may be used for parenteral administration or for other sterile applications. Definition: Potassium chloride contains not less than 99.0% and not more than 100.5% of KCl, calculated with reference to thedried substance. | ||
|
100000091807
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | |||
|
SUB12559MIG
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | |||
|
DB00761
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | |||
|
DTXSID5021178
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | |||
|
m9012
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | Merck Index | ||
|
Potassium chloride (medical use)
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | |||
|
1252
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | |||
|
D011189
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY | |||
|
4199
Created by
admin on Sat Dec 16 04:51:26 GMT 2023 , Edited by admin on Sat Dec 16 04:51:26 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Route of Elimination | PHARMACOKINETIC |
|
|
|||
MAXIMUM TOLERATED DOSE | TOXICITY |
|
SERUM POTASSIUM GREATER THAN 2.5 mEq/L: 200 mEq PER 24 HOURS |
|
||